$BULL

Denier Anthony Michael sold $516K of BULL

Denier Anthony Michael (President) sold 53,846 shares of Webull Corp (BULL) at $9.58 ($0.52M total) on 2026-09-08 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Denier Anthony Michael
Published Sep 9, 2026, 1:22 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 1:34 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BULL
Neutral
medium confidence
Mentioned
$BULL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BULLNeutralLow
01

Why it matters

The main tradable takeaway is sentiment around insider activity. However, 10b5-1 reduces the likelihood that the sale reflects new negative information.

02

Market read

A planned insider sale of about $516K is disclosed for BULL, which may cause minor sentiment noise but is unlikely to change fundamentals.

03

What to watch

The filing does not disclose reasons for the sale beyond the plan; traders should avoid extrapolating fundamentals from a single planned transaction.

Relevance 4/10Novelty 5/10Timing: filed 2026-09-08 after-hours; reflects sale executed 2026-09-08

Background

The article is an SEC Form 4 insider transaction disclosure for Webull Corp (BULL), reporting an open-market sale by an officer under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$BULLNeutralMedium confidence
Context

SEC Form 4 shows President Denier Anthony Michael sold 53,846 shares at $9.5774 on 2026-09-08 under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a primary Form 4 disclosure, but the transaction is explicitly under a Rule 10b5-1 plan, reducing interpretive weight versus non-plan sales.

Market effects

No sector-wide implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is pre-arranged under 10b5-1, it may not indicate bearish expectations and could be routine liquidity management.

Key entities

  • Webull Corp

    Subject of the Form 4 insider transaction disclosure.

  • Denier Anthony Michael

    President, officer/director who sold shares.

  • Rule 10b5-1 plan

    Pre-arranged plan that typically lowers interpretive signal of insider intent.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BULLHighAI 8/10

Class action alleges Webull misled investors about China operations

A class action lawsuit alleges Webull (BULL) misled investors about its China operations, claiming the company's SEC filings understated its reliance on China-based personnel and infrastructure. The complaint cites a 2025 registration statement showing 61% of employees were in China. Webull's stock reportedly dropped 19% after a congressional committee found discrepancies in the company's representations.

$BULLHigh

Why is Webull stock rallying today?

Webull Corp (BULL) rose 4.7% premarket after Scotiabank upgraded it to Sector Outperform with a $9 target, citing overreaction to regulatory concerns. Rosenblatt maintained a Buy rating, lowering its target to $12. The stock is near its 52-week low of $4.50. Broader market gains and fintech peer recovery also supported the rally.

$BULLHigh

Analysts view Webull selloff as overdone following House panel report; shares rise

Webull Corp (BULL) shares rose 4.2% premarket after Scotiabank upgraded it to Sector Outperform with a $9 target. The move follows a 20% drop on Wednesday due to a U.S. House report on its China ties. Scotiabank sees the selloff as overdone, while Rosenblatt cut its target to $12 but kept a Buy rating. Analysts believe regulatory risks are overstated and valuation is attractive.